Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
1 Align to Revenue Impact Link research questions to measurable business outcomes before starting
Our lead compounds are oral, brain-penetrant therapies that not only calm harmful immune activity but also repair myelin and restore vision-related function in preclinical models of Multiple Sclerosis
Discrepancies in results could be attributed to the different concentrations of TCA used besides combination treatment used in contrary to the monotherapy used in the current study 7
The role of carnitine in the management of cardiovascular diseases
75 ObeidR
CharpentierJWagetAKloppPMagnanCCruciani-GuglielmacciCLeeSJet al
US$ 29.92
US$ 29.53
US$ 20.51
US$ 21.90
US$ 26.27
US$ 28.09
